Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1 Exhibit Defective Heparan Sulfate Biosynthesis, Abnormal Placentation, and Late Embryonic Lethality
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Heparan sulfate (HS) plays critical roles in a variety of developmental, physiological, and pathogenic processes due to its ability to interact in a structure-dependent manner with numerous growth factors that participate in cellular signaling. The divergent structures of HS glycosaminoglycans are the result of the coordinate actions of several N- and O-sulfotransferases, C5-epimerase, and 6-O-endosulfatases. We have shown that 6-O-sulfation of the glucosamine residues in HS are catalyzed by the sulfotransferases HS6ST-1, -2, and -3. To determine the biological and physiological importance of HS6ST-1, we now describe the creation of transgenic mice that lack this sulfotransferase. Most of our HS6ST-1-null mice died between embryonic day 15.5 and the perinatal stage, and those mice that survived were considerably smaller than their wild-type littermates. Some of these HS6ST-1-null mice exhibited development abnormalities, and histochemical and molecular analyses of these mice revealed an approximately 50% reduction in the number of fetal microvessels in the labyrinthine zone of the placenta relative to that in the wild-type mice. Because we observed a modest reduction in VEGF-A mRNA and protein in the tissues of HS6ST-1-null mice, an HS-dependent defect in cytokine signaling probably contributes to increased embryonic lethality and decreased growth. Biochemical studies of the HS chains isolated from various organs of our HS6ST-1-null mice revealed a marked reduction of GlcNAc(6SO(4)) and HexA-GlcNSO(3)(6SO(4)) levels and a reduced ability to bind Wnt2. Thus, despite the presence of three closely related 6-O-sulfotransferase genes in the mouse genome, HS6ST-1 is the primary one used in HS biosynthesis in most tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
Fibroblast Growth Factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung
Bellusci, S., Grindley, J., Emoto, H., Itoh, N., & Hogan, B. L. M. (1997) · Development · doi:10.1242/dev.124.23.4867 · Cited by 1,003
Molecular diversity of heparan sulfate
Esko, J. D., & Lindahl, U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13530 · Cited by 951
Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., & Shima, D. T. (2002) · Genes & Development · doi:10.1101/gad.242002 · Cited by 914
Heparan sulphate proteoglycans: the sweet side of development
Häcker, U., Nybakken, K., & Perrimon, N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1681 · Cited by 683
Carmeliet, P., Ng, Y.-S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., et al. (1999) · Nature Medicine · doi:10.1038/8379 · Cited by 679
Tang, N., Wang, L., Esko, J., Giordano, F. J., Huang, Y., Gerber, H.-P., Ferrara, N., & Johnson, R. S. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.026 · Cited by 540
Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.
Zhang, X., Gaspard, J. P., & Chung, D. C. (2001) · PubMed · Cited by 519
Miner, J. H., Cunningham, J., & Sanes, J. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.6.1713 · Cited by 491
Research works printed but not linked: 5
- Thurlbeck, 1967, Am. Rev. Respir. Dis., 95, 752
- Balasubramaniam, 2003, Am. J. Physiol., 284, L964
- Zhang, 2001, Cancer Res., 61, 6050
- Izvolsky, 2003, Am. J. Physiol., 285, L838
- Lin, 1999, Nature, 400, 28128
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Thus for example, mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation and late embryonic lethality (1012) and autism-like socio-communicative deficits and stereotypes appear in mice lacking heparan sulfate only in the brain (1013).”
BackgroundSarrazin, S., Lamanna, W. C., & Esko, J. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004952 · Cited by 1,516
“H6st1 Glucosaminyl 6-Osulfotransferase 1 Null allele: embryonic lethal (Habuchi et al. 2007; Sugaya et al. 2008).”
BackgroundHeparan Sulfate: Biosynthesis, Structure, and Function
(2016) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2016.02.009 · Cited by 298
“6-OST1 rather than the other two isoforms appears to be principally responsible for 6-Osulfation of HS in most tissues (Habuchi et al., 2007).”
BackgroundChapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(09)76003-4 · Cited by 274
“6-OST1 rather than the other two recognized isoforms appears to be principally responsible for 6-O-sulfation of HS in most tissues (Habuchi et al., 2007).”
Proteoglycans and their roles in brain cancer
Wade, A., Robinson, A. E., Engler, J. R., Petritsch, C., James, C. D., & Phillips, J. J. (2013) · The FEBS Journal · doi:10.1111/febs.12109 · Cited by 193
Pathophysiology of heparan sulphate: many diseases, few drugs
Lindahl, U., & Kjellén, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12061 · Cited by 189
Survey of the year 2007 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2008) · Journal of Molecular Recognition · doi:10.1002/jmr.928 · Cited by 178
The heparanome and regulation of cell function: structures, functions and challenges
Ori, A. (2008) · Frontiers in Bioscience · doi:10.2741/3007 · Cited by 177
“Homozygous mutants present late embryonic lethality, impairment of placental function due to aberrant angiogenesis and lung deformation (104).”
BackgroundSulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis
Lemjabbar‐Alaoui, H., van Zante, A., Singer, M. S., Xue, Q., Wang, Y. Q., Tsay, D., He, B., Jablons, D. M., & Rosen, S. D. (2009) · Oncogene · doi:10.1038/onc.2009.365 · Cited by 153
“One mechanism for the spatiotemporal regulation of 6S in the embryo and adult is through expression of the heparan sulfate 6-O-sulfotransferases, which add sulfate esters to nascent HS chains (Brickman et al., 1998; Habuchi et al., 2004; Habuchi et al., 2007).”
Heparan sulfate proteoglycans: a sugar code for vertebrate development?
Poulain, F. E., & Yost, H. J. (2015) · Development · doi:10.1242/dev.098178 · Cited by 139
“Furthermore, various phenotypes have been reported for mice lacking Hs6st1 (Pratt et al., 2006; Habuchi et al., 2007; Izvolsky et al., 2008), whereas double Hs6st1 and Hs6st2 mutants have enhanced phenotypes and are embryonic lethal (Conway et al.”
BackgroundInfluentialSugaya, N., Habuchi, H., Nagai, N., Ashikari‐Hada, S., & Kimata, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705948200 · Cited by 133
Self-citationFunctions of Chondroitin Sulfate and Heparan Sulfate in the Developing Brain
Maeda, N., Ishii, M., Nishimura, K., & Kamimura, K. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0324-y · Cited by 117
“of 6-O-sulfation levels, which might lead to the impaired signaling of axon guidance molecules such as Slit [41, 43 ].”
BackgroundHeparan Sulfate-Dependent Signaling of Fibroblast Growth Factor 18 by Chondrocyte-Derived Perlecan
Chuang, C. Y., Lord, M. S., Melrose, J., Rees, M. D., Knox, S. M., Freeman, C. G., Iozzo, R. V., & Whitelock, J. M. (2010) · Biochemistry · doi:10.1021/bi1005199 · Cited by 115
The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source
Mižíková, I., & Morty, R. E. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00091 · Cited by 114
“Specifically concerning late lung development, defects in the development of the airspaces have been noted in both heparan sulfate 6-O-sulfotransferase 1 (Hs6st1) (182) and sulfatase 2 (Sulf2) (183) knockout mice.”
BackgroundMultifunctionality of extracellular and cell surface heparan sulfate proteoglycans
Kirn‐Safran, C. B., Farach‐Carson, M. C., & Carson, D. D. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0096-1 · Cited by 113
Ferreras, C., Rushton, G., Cole, C. L., Babur, M., Telfer, B. A., Kuppevelt, T. H. V., Gardiner, J. M., Williams, K. J., Jayson, G. C., & Avizienyte, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384875 · Cited by 101
“For example, HS6ST-1-deficient mice show abnormal organ morphogenesis and aberrant placental angiogenesis where microvessel density is reduced to about 60% (16).”
BackgroundDesign of biologically active heparan sulfate and heparin using an enzyme-based approach.
Peterson, S., Frick, A., & Liu, J. (2009) · Natural product reports (Print) · doi:10.1039/b803795g · Cited by 86
Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome
Cho, H., Shan, Y., Whittington, N. C., & Wray, S. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00121 · Cited by 99
Hossain, M. M., Hosono‐Fukao, T., Tang, R., Sugaya, N., Kuppevelt, T. H. V., Jenniskens, G. J., Kimata, K., Rosen, S. D., & Uchimura, K. (2009) · Glycobiology · doi:10.1093/glycob/cwp159 · Cited by 100
“The disaccharide compositions of the HS were determined by reverse-phase ion pair chromatography with a post-column fluorescent labeling as described previously (Habuchi et al. 2007).”
MethodSelf-citationChemical Tumor Biology of Heparan Sulfate Proteoglycans
Raman, K., & Kuberan, B. (2010) · Current Chemical Biology · doi:10.2174/187231310790226206 · Cited by 97
Pan, Y., Carbe, C., Powers, A., Zhang, E. E., Esko, J. D., Grobe, K., Feng, G.-S., & Zhang, X. (2008) · Development · doi:10.1242/dev.014829 · Cited by 96
“In addition, the Hs6st1 mutant mouse exhibits impaired lung alveolarization among other defects (Habuchi et al., 2007).”
BackgroundWhat Have We Learned from Glycosyltransferase Knockouts in Mice?
Stanley, P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.03.025 · Cited by 97
Functional Consequences of the Subdomain Organization of the Sulfs
Tang, R., & Rosen, S. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028472 · Cited by 95
The “in and out” of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate
Masri, R. E., Seffouh, A., Lortat‐Jacob, H., & Vivès, R. R. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9736-5 · Cited by 95
Qu, X., Carbe, C., Tao, C., Powers, A., Lawrence, R., van Kuppevelt, T. H., Cardoso, W. V., Grobe, K., Esko, J. D., & Zhang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225003 · Cited by 92
Endothelial Heparan Sulfate in Angiogenesis
Fuster, M. M., & Wang, L. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93009-3 · Cited by 94
Heparan Sulfate 2-O-Sulfotransferase Is Required for Triglyceride-rich Lipoprotein Clearance
Stanford, K. I., Wang, L., Castagnola, J., Song, D., Bishop, J. R., Brown, J. R., Lawrence, R., Bai, X., Habuchi, H., Tanaka, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063701 · Cited by 84
Self-citationProteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation
Pessentheiner, A. R., Ducasa, G. M., & Gordts, P. L. S. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00769 · Cited by 80
“WNT and FGF binding to HS and hence their respective signaling modalities are regulated by HS, in particular via 6O-sulfation (52, 53).”
BackgroundHeparan sulfate in angiogenesis: a target for therapy
van Wijk, X. M. R., & Kuppevelt, T. H. V. (2013) · Angiogenesis · doi:10.1007/s10456-013-9401-6 · Cited by 86
Huegel, J., Sgariglia, F., Enomoto‐Iwamoto, M., Koyama, E., Dormans, J. P., & Pacifici, M. (2013) · Developmental Dynamics · doi:10.1002/dvdy.24010 · Cited by 86
Heparan Sulfate in the Developing, Healthy, and Injured Lung
Haeger, S. M., Yang, Y., & Schmidt, E. P. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0043tr · Cited by 78
“Ext1/Ext2 Elongates HS chain Null allele: embryonic lethal; aberrant endoderm development (57, 58) Ndst1 Deacetylates and sulfates glucosamine residues at the N position Null allele: perinatal lethal; pulmonary hypoplasia and neonatal respiratory distress (5, 6) H6st1 Sulfates glucosamine residues at the 6 position Nu…”
BackgroundCarlsson, P., & Kjellén, L. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23056-1_2 · Cited by 78
“Thus, heparin 6-O-sulfation preferentially relies on 6-OST-2 and/or 6-OST-3, at least in skin mast cells (Habuchi et al. 2007).”
BackgroundYue, X., Li, X., Nguyen, H. T., Chin, D. R., Sullivan, D. E., & Lasky, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802850200 · Cited by 78
Specific Glycosaminoglycans Modulate Neural Specification of Mouse Embryonic Stem Cells
Pickford, C. E., Holley, R. J., Rushton, G., Stavridis, M. P., Ward, C. M., & Merry, C. L. R. (2011) · Stem Cells · doi:10.1002/stem.610 · Cited by 77
Wong, G. W., Zhuo, L., Kimata, K., Lam, B. K., Satoh, N., & Stevens, R. L. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.124 · Cited by 74
Self-citationHuegel, J., Mundy, C., Sgariglia, F., Nygren, P., Billings, P. C., Yamaguchi, Y., Koyama, E., & Pacifici, M. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.02.008 · Cited by 73
“Ablation of Perlecan or Glypican-3 genes, both of which encode HSPG core proteins and are expressed in the growth plate, also results in growth plate and skeletal abnormalities (Arikawa-Hirasawa et al., 1999; Habuchi et al., 2007; Viviano et al., 2005; Yasuda et al., 2010).”
Heparan sulfate in the regulation of neural differentiation and glioma development
Xiong, A., Kundu, S., & Forsberg‐Nilsson, K. (2014) · FEBS Journal · doi:10.1111/febs.13097 · Cited by 66
Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling
Garner, O. B., Bush, K. T., Nigam, K. B., Yamaguchi, Y., Xu, D., Esko, J. D., & Nigam, S. K. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.04.035 · Cited by 55
“Systemically, mutations in Hs6st and Hsglce show perinatal embryonic lethality (Habuchi et al., 2007; Izvolsky et al., 2008; Li et al., 2003), but whether mammary buds exist in these animals is not known.”
BackgroundSuzuki, K., Okada, H., Takemura, G., Takada, C., Tomita, H., Yano, H., Muraki, I., Zaikokuji, R., Kuroda, A., Fukuda, H., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15153 · Cited by 62
“Thus, heparan sulfate has important functions in a variety of developmental, morphogenetic and pathogenic processes (Habuchi et al., 2007).”
BackgroundGenetics and pathophysiology of mammalian sulfate biology
Langford, R., Hurrion, E. M., & Dawson, P. A. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.08.001 · Cited by 59
Heparan sulfate as a regulator of endochondral ossification and osteochondroma development
Jochmann, K., Bachvarova, V., & Vortkamp, A. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.11.003 · Cited by 58
The function of heparan sulfate during branching morphogenesis
Patel, V. N., Pineda, D. L., & Hoffman, M. P. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.09.004 · Cited by 57
“Genetic deletions of HSPGs and HS sulfotransferases in mice that display a branching phenotype Gene/mutation Branching phenotype Col18a1 -/Defective basement membrane formation-leading to hydrocephalus and anterior ocular defects (30) Thickened basement membrane with reduced filtration capacity (31) Sdc1 -/Reduced sec…”
BackgroundDziedzic, D., Węgrzyn, G., & Jakóbkiewicz‐Banecka, J. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.144 · Cited by 57
Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis
Kumagai, T., SATO, T. A., Natsuka, S., Kobayashi, Y., Zhou, D., Shinkai, T., Hayakawa, S., & Furukawa, K. (2010) · Glycoconjugate Journal · doi:10.1007/s10719-010-9313-2 · Cited by 56
Human genetic disorders and knockout mice deficient in glycosaminoglycan
Mizumoto, S., Yamada, S., & Sugahara, K. (2014) · BioMed Research International · doi:10.1155/2014/495764 · Cited by 54
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis
Gordts, P. L. S. M., & Esko, J. D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.010 · Cited by 54
Hepatic Heparan Sulfate Proteoglycans and Endocytic Clearance of Triglyceride-Rich Lipoproteins
Foley, E. M., & Esko, J. D. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93010-x · Cited by 54
“The lack of phenotype might reflect a partial reduction in glucosamine 6-O-sulfation in Hs6st1f/fAlbCreþ hepatocytes due to the expression of other Hs6st isoforms or the enrichment of trisulfated disaccharides.(91) However, 6-O-desulfated heparin competed for lipoprotein binding, at the surface of primary hepatocytes,…”
BackgroundHoward, S. R., Oleari, R., Poliandri, A., Chantzara, V., Fantin, A., Ruiz‐Babot, G., Metherell, L., Cabrera, C., Barnes, M. R., Wehkalampi, K., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00646 · Cited by 50
“The viability of Hs6st1 mice is in contrast to that of Hs6st1 knockout (Hs6st1) mice, which could not be examined for puberty defects due to embryonic lethality (36).”
Up-Regulation of Heparan Sulfate 6-O-Sulfation in Idiopathic Pulmonary Fibrosis
Lu, J., Auduong, L., White, E. S., & Yue, X. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0204oc · Cited by 45
“HS6ST1-deficient mice exhibit marked reduction of GlcNAc-6S and UA-GlcNS-6S residues in the HS isolated from the lung, and the defective lung morphology with enlarged alveolar spaces accompanied by abnormal elastin pattern suggestive of emphysematous changes (41, 42).”
BackgroundJones, M. R., Chong, L., & Bellusci, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.620667 · Cited by 43
“For example, in one study where heparan sulfate 6-O-sulfotransferase1 (Hs6st1) was genetically inactivated, defects on the developing lung were not reported (Habuchi et al., 2007), even though late embryonic mortality was observed.”
BackgroundSong, K., Li, Q., Peng, Y., Li, J., Ding, K., Chen, L., Shao, C., Zhang, L., & Li, P. (2011) · Biochemical Journal · doi:10.1042/bj20110297 · Cited by 43
Oleari, R., Massa, V., Cariboni, A. M., & Lettieri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179425 · Cited by 41
Wang, X., Cho, H., Campbell, M. R., Panduri, V., Coviello, S., Caballero, M. T., Sambandan, D., Kleeberger, S. R., Polack, F. P., Ofman, G., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01272-0 · Cited by 40
“addition, AGER, a specific alveolar type 1 cell differentiation marker [50], and HS6ST1 encoding heparin sulfate 6-O-sufotransferase 1 [69] involve in alveolar development.”
BackgroundHeparan Sulfates in the Lung: Structure, Diversity, and Role in Pulmonary Emphysema
Smits, N. C., Shworak, N. W., Dekhuijzen, P. N. R., & Kuppevelt, T. H. V. (2010) · The Anatomical Record · doi:10.1002/ar.20895 · Cited by 40
“Airspace enlargement during postnatal period associated with abnormal elastin deposition (Habuchi et al., 2007) SULF-2 Incompletely penetrant lung phenotype, including enlarged air spaces (Lum et al., 2007).”
BackgroundMethodInfluentialRudd, T. R., & Yates, E. A. (2012) · Molecular BioSystems · doi:10.1039/c2mb25019e · Cited by 40
Louden, E. D., Poch, A., Kim, H., Ben‐Mahmoud, A., Kim, S., & Layman, L. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111334 · Cited by 38
Role of sulphate in development
Dawson, P. A. (2013) · Reproduction · doi:10.1530/rep-13-0056 · Cited by 38
Izvolsky, K. I., Lü, J., Martin, G. S., Albrecht, K. H., & Cardoso, W. V. (2008) · genesis · doi:10.1002/dvg.20355 · Cited by 38
“O endosulfatase Sulf2 genes (Habuchi et al., 2007; Lum et al., 2007).”
BackgroundResultInfluentialMice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1
Habuchi, H., & Kimata, K. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93005-6 · Cited by 36
Self-citationDatta, P., Li, G., Yang, B., Zhao, X., Baik, J. Y., Gemmill, T. R., Sharfstein, S. T., & Linhardt, R. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.519033 · Cited by 34
McCarthy, K. J., & Wassenhove-McCarthy, D. J. (2012) · Microscopy and Microanalysis · doi:10.1017/s1431927611012682 · Cited by 36
“…of some, but not all, of the enzymes involved in postassembly modification of glycosaminoglycan chains often permitted full length gestation of murine fetuses but often led to peri-/post-natal lethality due to compromise of one or more organ systems ~Bullock et al., 1998; Habuchi et al., 2007!.”
BackgroundIn vivo manipulation of heparan sulfate structure and its effect on Drosophila development
Kamimura, K., Maeda, N., & Nakato, H. (2010) · Glycobiology · doi:10.1093/glycob/cwq202 · Cited by 33
“Mutations in HSME genes induce specific developmental defects by interfering with growth factor signaling (Bullock et al. 1998; Li et al. 2003; Habuchi et al. 2007).”
BackgroundAnower-E-Khuda, M. F., Habuchi, H., Nagai, N., Habuchi, O., Yokochi, T., & Kimata, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416651 · Cited by 32
“We previously showed that the proportion of 6-O-sulfatebearing units in HS extracted from the various tissues of HS6ST-1 / mice was much lower than that in HS obtained fromWT mice (11).”
BackgroundMethodResultSelf-citationJiang, T., Hu, W., Zhang, S., Ren, C., Lin, S., Zhou, Z., Wu, H., Yin, J., & Tan, L. (2022) · Respiratory Research · doi:10.1186/s12931-022-02193-5 · Cited by 31
“HS6ST1 is considered to be essential in lung development, and HS6ST1-deficiency in mice exhibit airspace enlargement during postnatal period associated with abnormal elastin deposition [44].”
BackgroundMoon, S., & Zhao, Y.-T. (2021) · Glycobiology · doi:10.1093/glycob/cwab054 · Cited by 29
2-O-sulfotransferase regulates Wnt signaling, cell adhesion and cell cycle during zebrafish epiboly
Cadwalader, E. L., Condic, M. L., & Yost, H. J. (2012) · Development · doi:10.1242/dev.078238 · Cited by 29
Essential Role of Heparan Sulfate 2-O-Sulfotransferase in Chick Limb Bud Patterning and Development
Kobayashi, T., Habuchi, H., Tamura, K., Ide, H., & Kimata, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610707200 · Cited by 29
Self-citationGenetic Analysis of the Heparan Modification Network in Caenorhabditis elegans
Townley, R. A., & Bülow, H. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227926 · Cited by 27
The endothelial glycocalyx—All the same? No, it is not
Suzuki, K., Miura, T., & Okada, H. (2023) · Acute Medicine & Surgery · doi:10.1002/ams2.896 · Cited by 26
“49 The expression of HS6ST1 is associated with the synthetic repair of heparan sulfate.”
BackgroundGrowth factor–heparan sulfate “switches” regulating stages of branching morphogenesis
Nigám, S. K., & Bush, K. T. (2014) · Pediatric Nephrology · doi:10.1007/s00467-013-2725-z · Cited by 26
“Wnt Activity stimulated by desulfation at 6-O-position [53]”
BackgroundNagai, N., Habuchi, H., Sugaya, N., Nakamura, M., Imamura, T., Watanabe, H., & Kimata, K. (2013) · Glycobiology · doi:10.1093/glycob/cwt037 · Cited by 26
Self-citationAntiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site
Li, M., & Xu, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005859117 · Cited by 25
Conway, C. D., Price, D. J., Pratt, T., & Mason, J. O. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01432.x · Cited by 25
“However, mice homozy- gous for a null allele of Hs6st1 generated by gene-targeting have been reported to have a similarly low postnatal sur- vival rate, attributed to defects in placental development (Habuchi et al. 2007).”
BackgroundInfluentialHeparan sulfate in lung morphogenesis: The elephant in the room
Thompson, S. M., Jesudason, E. C., Turnbull, J. E., & Fernig, D. G. (2010) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20169 · Cited by 24
Glycosaminoglycan and growth factor mediated murine calvarial cell proliferation
Manton, K. J., Haupt, L. M., Vengadasalam, K., Nurcombe, V., & Cool, S. M. (2007) · Journal of Molecular Histology · doi:10.1007/s10735-007-9121-6 · Cited by 23
“These HSPGs interact with a large number of growth factors and morphogens, in particular fibroblast growth factor (FGF) and its associated receptors (FGFRs) (Habuchi et al. 2007; Ling et al. 2006).”
BackgroundSpecific sides to multifaceted glycosaminoglycans are observed in embryonic development
Kramer, K. L. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.06.002 · Cited by 23
Glycans in Diseases and Therapeutics
Pavão, M. S. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8 · Cited by 24
Epigenetic modifications in the development of bronchopulmonary dysplasia: a review
Wang, L., Xiao, J., Zhang, B., & Hou, A. (2024) · Pediatric Research · doi:10.1038/s41390-024-03167-7 · Cited by 22
“30 Postpartum BPD infants often show increased in fl ammation.”
Jochmann, K., Bachvarova, V., & Vortkamp, A. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.04.001 · Cited by 22
van Wijk, X. M. R., Oosterhof, A., van den Broek, S. A. M. W., Griffioen, A. W., ten Dam, G. B., Rutjes, F. P. J. T., van Delft, F. L., & Kuppevelt, T. H. V. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.025 · Cited by 22
Enzymatic Placement of 6-O-Sulfo Groups in Heparan Sulfate
Liu, R., & Liu, J. (2011) · Biochemistry · doi:10.1021/bi200072t · Cited by 21
Gorsi, B., Liu, F., Ma, X., Chico, T., Shrinivasan, A., Kramer, K. L., Bridges, E., Monteiro, R. M., Harris, A. L., Patient, R. K., et al. (2013) · Angiogenesis · doi:10.1007/s10456-013-9379-0 · Cited by 21
Buresh‐Stiemke, R. A., Malinowski, R. L., Keil, K. P., Vezina, C. M., Oosterhof, A., Kuppevelt, T. H. V., & Marker, P. C. (2012) · Developmental Dynamics · doi:10.1002/dvdy.23886 · Cited by 21
“Multiple studies have shown that these enzymes are critical for normal development in both vertebrates and invertebrates (Danesin et al., 2006; Habuchi et al., 2007; Kleinschmit et al., 2010), and our previous study implicated down-regulation of Sulf1 as an important feature of prostate development…”
BackgroundHeparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells
Reine, T. M., Kusche‐Gullberg, M., Feta, A., Jenssen, T. G., & Kolset, S. O. (2011) · Glycoconjugate Journal · doi:10.1007/s10719-011-9365-y · Cited by 20
Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis
Piszczatowski, R. T., Bülow, H. E., & Steidl, U. G. (2024) · Blood · doi:10.1182/blood.2023022736 · Cited by 20
Physiology and Pathophysiology of Heparan Sulfate in Animal Models: Its Biosynthesis and Degradation
Mashima, R., Okuyama, T., & Ohira, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041963 · Cited by 19
“Hs6st1(−/−) Neural ↓Retinal ganglion cell-mediated axon formation; ↑prolific inter-retinal innervation [111]”
Xiong, A., Kundu, S., Forsberg, M., Xiong, Y., Bergström, T., Paavilainen, T., Kjellén, L., Li, J., & Forsberg‐Nilsson, K. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.11.007 · Cited by 18
N-Sulfation of Heparan Sulfate Regulates Early Branching Events in the Developing Mammary Gland
Bush, K. T., Crawford, B. E., Garner, O. B., Nigam, K. B., Esko, J. D., & Nigám, S. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423327 · Cited by 17
Buresh‐Stiemke, R. A., Kuslak, S. L., Rusch, M. A., Vezina, C. M., Selleck, S. B., & Marker, P. C. (2010) · Endocrinology · doi:10.1210/en.2009-1359 · Cited by 17
Involvement of Heparan Sulfate and Heparanase in Neural Development and Pathogenesis of Brain Tumors
Xiong, A., Spyrou, A., & Forsberg‐Nilsson, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_14 · Cited by 17
Rada, C. C., Pierce, S., Nuno, D. W., Zimmerman, K., Lamping, K. G., Bowdler, N. C., Weiss, R. M., & England, S. K. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2012 · Cited by 17
“Pregnancy-associated increases in stroke volume (55%), cardiac output (71%), and HR (7%) of the P18 WT mice were comparable to values in other studies of cardiovascular adaptations in the mouse in late pregnancy (Table 1) (13).”
ResultDawson, P. A., Richard, K., Perkins, A. V., Zhang, Z., & Simmons, D. G. (2017) · Placenta · doi:10.1016/j.placenta.2017.01.001 · Cited by 16
Thompson, S. M., Connell, M. G., Kuppevelt, T. H. V., Xu, R., Turnbull, J. E., Losty, P. D., Fernig, D. G., & Jesudason, E. C. (2011) · BMC Developmental Biology · doi:10.1186/1471-213x-11-38 · Cited by 15
“In the mammalian lung, chemical inhibition of HS sulfation prevents FGF10 induced epithelial budding [30] and HS6ST1 deficient mice exhibit impaired alveolarisation [54].”
BackgroundFunctional analysis of chick heparan sulfate 6‐O‐sulfotransferases in limb bud development
Kobayashi, T., Habuchi, H., Nogami, K., Ashikari‐Hada, S., Tamura, K., Ide, H., & Kimata, K. (2010) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2009.01148.x · Cited by 15
“Heparan sulfate 6-Osulfotransferase-1 (HS6ST-1) deficient mice show reduced fetal microvessels in the labyrinthine zone of the placenta and are late embryonic lethal (Habuchi et al. 2007).”
BackgroundSelf-citationHeparan Sulfate Biosynthesis Enzymes in Embryonic Stem Cell Biology
Tamm, C., Kjellén, L., & Li, J. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412465090 · Cited by 15
“Most glucosaminyl 6-O-sulfotransferase 1 (Hs6st1) knockout embryos died during late gestation, and those that survived were smaller than wild-type littermates, with various developmental abnormalities (Habuchi et al. 2007).”
BackgroundOverview of the current procedures in synthesis of heparin saccharides
Zhao, S., Zhang, T., Kan, Y., Li, H., & Li, J. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122220 · Cited by 14
Heparan Sulfate Proteoglycans as Multifunctional Cell Regulators: Cell Surface Receptors
Li, J., & Spillmann, D. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-498-8_16 · Cited by 13
Identification of Rare Variants Involved in High Myopia Unraveled by Whole Genome Sequencing
Haarman, A. E. G., Klaver, C. C. W., Tedja, M. S., Roosing, S., Astuti, G., Gilissen, C., Hoefsloot, L. H., van Tienhoven, M., Brands, T., Magielsen, F. J., et al. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100303 · Cited by 11
“58,59 RNA binding motif protein 20 ( RMB20 ) encodes the RNA-binding motif protein 20, which regulates the splicing of several genes involved in ion homeostasis, cardiomyopathy (MIM 613172), and sarcomere biology.”
RB4CD12 epitope expression and heparan sulfate disaccharide composition in brain vasculature
Hosono‐Fukao, T., Ohtake‐Niimi, S., Nishitsuji, K., Hossain, M. M., Kuppevelt, T. H. V., Michikawa, M., & Uchimura, K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22690 · Cited by 10
“The HS was purified by DEAE-Sepharose column chromatography as reported previously (Habuchi et al., 2007).”
MethodA glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm
Piszczatowski, R. T., Schwenger, E., Sundaravel, S., Stein, C. M., Liu, Y., Stanley, P., Verma, A. K., Zheng, D., Seidel, R. D., Almo, S. C., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212552 · Cited by 10
Metadata
- Authors
- Habuchi, H., Nagai, N., Sugaya, N., Atsumi, F., Stevens, R. L., & Kimata, K.
- Affiliations
- Aichi Medical University (JP)
- Institute for Molecular Science of Medicine, Aichi Medical University (JP)
- Brigham and Women's Hospital (US)
- Corresponding author
- Kimata, Koji
- ORCID
- Kimata, Koji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 21
- Pages
- 15578-15588
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2164205795
- Cited by
- 139
- References
- 58
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 11 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 1 · 2016: 9 · 2015: 7 · 2014: 7 · 2013: 13 · 2012: 9
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4903 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- heparan sulfate, heparan sulfate biosynthesis, embryonic lethality, placental development, VEGF-A, cytokine signaling, glycosaminoglycans, transgenic mice
- MeSH terms
- Animals, Female, Heparan Sulfate, Placenta, Placenta Diseases, Placentation, Pregnancy, Sulfotransferases, Signal Transduction, Mice, Knockout, Gene Expression Regulation, Developmental, Embryo Loss, Vascular Endothelial Growth Factor A, Embryonic Development, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.